Benchmark Maintains a 'Hold' on Moody's Corp (MCO); Adjusting Numbers After Q4 and Guidance
MCO Hot Sheet
Rating Summary:1 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 82
Benchmark maintains a 'Hold' on Moody's Corp (NYSE: MCO) price target raised from $34 to $37.
Benchmark analyst says, "Moody’s reported soft top-line results in 4Q11. Expenses increased resulting in an operating income decline of 13% y/y. However, 2012 guidance called for high-single to low-double digit percentage revenue growth and a mid-point of EPS growth at 9% y/y. Despite decent guidance, we remain cautious given growth is back half weighted."
"For 2012, we estimate total revenue of $2.5 billion, up 9% y/y. We estimate MIS revenue of $1.65 billion, up 6%, and MA revenue of $813 million, up 17%. Our 2011 EPS estimate is $2.65, up 8% y/y."
For an analyst ratings summary and ratings history on Moody's Corp click here. For more ratings news on Moody's Corp click here.
Shares of Moody's Corp closed at $38.31 yesterday, with a 52 week range of $26.79-$41.93.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
Benchmark analyst says, "Moody’s reported soft top-line results in 4Q11. Expenses increased resulting in an operating income decline of 13% y/y. However, 2012 guidance called for high-single to low-double digit percentage revenue growth and a mid-point of EPS growth at 9% y/y. Despite decent guidance, we remain cautious given growth is back half weighted."
"For 2012, we estimate total revenue of $2.5 billion, up 9% y/y. We estimate MIS revenue of $1.65 billion, up 6%, and MA revenue of $813 million, up 17%. Our 2011 EPS estimate is $2.65, up 8% y/y."
For an analyst ratings summary and ratings history on Moody's Corp click here. For more ratings news on Moody's Corp click here.
Shares of Moody's Corp closed at $38.31 yesterday, with a 52 week range of $26.79-$41.93.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- Barclays Maintains an 'Overweight' on Tidewater (TDW); Dayrates Climb, But Adjusting Numbers Lower on Expenses
- Nomura Securities Maintains a 'Neutral' on Yahoo! (YHOO); Monetizing Alibaba
- Canaccord Genuity maintains a 'Buy' on Auxilium Pharmaceuticals (AUXL); Bumping Guidance on Testim Partnership with GSK
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
